SI-BONE, Inc.

NASDAQ:SIBN

Medical - Devices

Healthcare
$23.54 +3.45%

+$0.53 today

Market cap
$1.06B
Beta
0.70
P/E (TTM)
-41.4
EPS (TTM)
-$0.38
52W Low $11.48High $21.89

Volume 1.12M

Average 0.68M

SIBN Total Assets

Everything the company owns or controls; equal to total liabilities plus equity.

SI-BONE, Inc.NASDAQ: SIBN

Total Assets · Q1 FY2026 · quarter ended Mar 2026

Total assets rises 6.8% from a year ago

Total assets stood at $242.72M at the end of Q1 FY2026, up 6.8% from a year earlier and up 1.7% from the prior quarter. Over 3 fiscal years it compounded at +14.8% a year.

Context

  • Total assets increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether total assets keeps rising in the next quarterly balance sheet after a +6.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$242.72M+1.7% QoQ
Last fiscal yearDec 2025
$238.56M+3.5% YoY
Year agoMar 2025
$227.28M+6.8% since
Total Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+6.8%——
1 year+3.5%——
3-year CAGR+14.8%——
5-year CAGR——
10-year CAGR——

Total Assets history

USD · from the balance sheet

Latest · FY2025
238.56M USD
Year-over-year change
+3.5%
4-year CAGR
+5.8%

Total Assets vs competitors

How SIBN compares with its peers on the latest reported figures

  • SIBN's Mar 2026 total assets of $242.72M is the lowest of the 6 companies compared; the peer median is $5.49B.
  • Its year-over-year change of +6.8% is the 2nd highest of 6, against a peer median of +1.8%.
  • Over three fiscal years its annual growth of +14.8% compares with a peer median of +9.1%.
SIBN Competitors Peer median
Total Assets for SIBN and competitors
Company Period Latest balance YoY 3-year CAGR
SYKStryker CorporationJun 2026$47.93B +3.5%+9.1%
SNNSmith & Nephew plcDec 2025$10.46B +1.0%+1.6%
GMEDGlobus Medical, Inc.Jun 2026$5.49B +10.6%+36.7%
CNMDCONMED CorporationMar 2026$2.31B +0.8%+0.4%
ATECAlphatec Holdings, Inc.Mar 2026$799.48M +1.8%+14.9%
SIBNSI-BONE, Inc.Mar 2026$242.72M +6.8%+14.8%
Peer median (excluding SIBN) $5.49B+1.8%+9.1%

Competitors are the stored peer set for SIBN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents63.42M20.72M33.27M34.95M42.24M
Short-term Investments83.56M76.57M132.75M115.09M105.58M
Net Receivables14.25M20.67M21.95M27.46M29.92M
Inventory11.5M17.28M20.25M27.07M33.9M
Other Current Assets02.37M3.17M3.2M4.48M
Total Current Assets175.87M137.61M211.39M207.78M216.12M
Property, Plant & Equipment (Net)14.24M19.57M18.71M22.36M22.39M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets400K375K325K300K55K
Total Non-current Assets14.64M19.94M19.03M22.66M22.44M
Total Assets190.51M157.55M230.43M230.44M238.56M
Account Payables3.2M6.28M4.59M6.49M4.63M
Short-term Debt0000944K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities11.36M12.34M15.16M14.85M19.7M
Total Current Liabilities16.89M21.18M23.46M27.13M25.28M
Long-term Debt34.97M35.17M36.07M35.45M175K
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities57K30K18K10K35.57M
Total Non-current Liabilities39.2M38.07M37.59M36.34M35.74M
Total Liabilities56.09M59.25M61.05M63.47M61.02M
Common Stock3K3K4K4K4K
Retained Earnings(295.85M)(357.11M)(400.44M)(431.35M)(450.26M)
Accumulated OCI352K232K335K244K816K
Other Stockholders Equity00000
Minority Interest00000
Total Equity134.42M98.3M169.38M166.96M177.53M
Total Debt40.48M39.43M38.99M37.48M1.12M
Net Debt(22.94M)18.71M5.72M2.54M(41.12M)

SI-BONE, Inc.

NASDAQ:SIBN

Intrinsic Alpha fair value

Locked

Current Price

$23.54

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.